Prognosis of acute coronary syndrome complicated by stress hyperglycemia after percutaneous coronary intervention therapy

被引:1
|
作者
申健 [1 ]
李志明 [1 ]
何丽珍 [1 ]
刘锦光 [1 ]
申源生 [1 ]
罗晓丽 [1 ]
机构
[1] Department of Cardiology,Huizhou Municipal Central Hospital
关键词
stress hyperglycemia; acute coronary syndrome; prognosis;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
Background Several studies have reported an association of hyperglycemia with increased mortality and complications in hospital patients with acute coronary syndrome(ACS).However,the influence of stress hyperglycemia(SH)on the medium-and long-term prognoses in ACS patients has not yet been determined.Methods Random venous blood glucose levels were determined in 433 ACS patients and the patients were divided into two groups based on blood glucose results and disease histories.The 171 patients included in the experimental group had no history of diabetes,had no diabetes and/or glucose metabolism disorders during hospitalization and follow-up and had fasting blood glucose levels of≥7.0 mmol/L and random blood glucose levels≥11.1 mmol/L.The 262 patients included in the control group had no history of diabetes,had no diabetes and/or glucose metabolism disorders during hospitalization and follow-up,and had fasting blood glucose levels<6.1 mmol/L and random blood glucose levels<7.8 mmol/L.Basic clinical information,coronary angiographic lesion characteristics,PCI success rate,complication rate,incidence and morbidity rate of cardiovascular events during the hospitalization period and 6 years of follow-up were compared between the two groups.Results There was no significant difference in age,gender or disease history between the two groups.The triglyceride levels and the left ventricular ejection fractions were significantly higher(P=0.00)and significantly lower(P=0.03)in the experimental group than in the control group,respectively.Both groups were subjected to coronary angiography and PCI.The PCI success rates of the two groups did not differ significantly(P=0.63).The experimental group had more type B2 lesions,but fewer type A lesions compared with the control group.The experimental group had significantly more stents implanted compared with the control group(P<0.05).The cardiovascular events were significantly increased(P=0.01)in the experimental group compared with the control group 1 year after discharge.The incidence of cardiovascular events did not differ significantly between the two groups 1-2 years after discharge.The event incidences were significantly higher(P=0.05)in the experimental group than in the control group at the end of follow-up.The experimental group was more prone to myocardial infarction and ischemic target vessel revascularization than the control group,but the control group was more prone to unstable stenocardia and heart failure than the experimental group.The psychogenic mortality of the two groups were similar.The interval and the overall mortality rates(P=0.054)of the two groups were also similar.Conclusions Patients with ACS complicated by SH were more likely to have cardiovascular events 1 year after PCI,whereas SH did not affect the mid-or long-term prognoses of these patients.SH is an independent risk factor for cardiovascular events.
引用
收藏
页码:243 / 251 +256
页数:10
相关论文
共 50 条
  • [1] Antithrombotic therapy after acute coronary syndrome or percutaneous coronary intervention
    Zado, Erica S.
    HEART RHYTHM, 2022, 19 (05)
  • [2] Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Man Wang
    Wen Su
    Ning Cao
    Hui Chen
    Hongwei Li
    Cardiovascular Diabetology, 22
  • [3] Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Wang, Man
    Su, Wen
    Cao, Ning
    Chen, Hui
    Li, Hongwei
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [4] Prognosis of patients with acute coronary syndrome submitted to percutaneous coronary intervention
    Sousa, P. J.
    Teles, R. C.
    Goncalves, P. A.
    Almeida, M. S.
    Cale, R.
    Brito, J.
    Raposo, L.
    Palos, J. L.
    Baptista, J.
    Silva, J. A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 361 - 361
  • [5] Improved prognosis in acute coronary syndrome by means of acute percutaneous coronary intervention even after transfer
    Oeff, M
    Ohlmeier, H
    Goos, H
    Hempel, A
    Huget, H
    Goesswald, A
    Wolf, U
    EUROPEAN HEART JOURNAL, 2004, 25 : 358 - 358
  • [6] Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    Faxon, David P.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) : 181 - 197
  • [7] Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Bagai, Akshay
    Bhatt, Deepak L.
    Eikelboom, John W.
    Mancini, G. B. John
    Cohen, Eric A.
    Vijayaraghavan, Ram
    Cheema, Asim N.
    Udell, Jacob A.
    Niznick, Joel
    Tanguay, Jean-Francois
    Verma, Subodh
    Mehta, Shamir R.
    CIRCULATION, 2016, 133 (21) : 2094 - 2098
  • [8] Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome
    Higuchi, Satoshi
    Kabeya, Yusuke
    Nishina, Yoshio
    Miura, Yusuke
    Yoshino, Hideaki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (07) : E666 - E673
  • [9] Percutaneous coronary intervention in acute coronary syndrome
    Yamaguchi, T
    Nakamura, M
    Mitsuo, K
    Matsuda, K
    INTERNAL MEDICINE, 2000, 39 (04) : 337 - 338
  • [10] Patients' Perspectives With Acute Coronary Syndrome After Percutaneous Coronary Intervention
    Qin, Hong
    Mayer, Hanna
    Ozturk, Begum
    Eslam, Roza Badr
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2021, 17 (05): : 588 - 593